サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1709463

非侵襲的ヘリコバクターピロリ検査の世界市場：検査の種類別・技術別・流通チャネル別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

Non-invasive Helicobacter Pylori Testing Market, By Test Type, By Technology, By Distribution, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 298 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
非侵襲的ヘリコバクターピロリ検査の世界市場：検査の種類別・技術別・流通チャネル別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2025年04月04日
発行: AnalystView Market Insights
ページ情報: 英文 298 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

非侵襲的ヘリコバクターピロリ検査の市場規模は2024年に2億9,733万米ドルとなり、2025年から2032年にかけてCAGR 7.50%で拡大

非侵襲的ヘリコバクターピロリ検査の市場力学

利便性を追求した家庭用ピロリ菌検査キットへの需要の高まり

家庭用ピロリ菌検査キットに対する需要の高まりは、非侵襲性ピロリ菌検査市場の主要促進要因です。消費者は、臨床受診の必要性をなくす便利な自宅診断ソリューションを好みます。これらのキットはプライバシーが守られ、使いやすく、迅速な結果が得られるため、早期発見には魅力的です。遠隔医療やデジタル医療プラットフォームの台頭は、検査結果に基づく遠隔診察を可能にし、その採用をさらに後押ししています。さらに、胃の病気や予防医療に対する意識の高まりも市場の成長を後押ししています。迅速抗原検査や呼気検査技術の進歩は、在宅検査の精度と信頼性を高める。自己検査ソリューションに対する規制当局の承認は、特に医療インフラが限られている地域でのアクセシビリティを拡大しています。eコマースの普及拡大も売上を押し上げ、これらのキットを広く入手可能にしています。医療が個別化医療や予防医療にシフトする中、在宅ピロリ菌検査は強い需要が見込まれます。

非侵襲的ヘリコバクターピロリ検査市場：主な考察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2025-2032年）に約7.50%のCAGRで毎年成長すると予測されています。

検査の種類別では、尿素呼気試験（UBT）が2024年に最大市場シェアを示すと予測されます。

技術別では、2024年には分子診断法が主要技術でした。

流通チャネル別では、2024年には病院薬局が主要流通でした。

エンドユーザー別では、2024年に病院・診療所が主要エンドユーザーでした。

地域別では、アジア太平洋地域が2024年の売上高をリードしています。

非侵襲的ヘリコバクターピロリ検査市場：セグメンテーション分析

非侵襲的ヘリコバクター・ピロリ検査の世界市場は、検査の種類、技術、流通、エンドユーザー、地域に基づいてセグメント化されます。

市場は検査の種類に基づいて3つのカテゴリーに分けられます：尿素呼気試験（UBT）、便抗原試験（SAT）、血液抗体試験です。尿素呼気試験（UBT）は、高い精度、使いやすさ、活動性感染の検出における信頼性により、非侵襲的ピロリ菌検査市場を独占しています。過去と現在の感染を区別できない血液抗体検査とは異なり、UBTはピロリ菌の存在を示す重要なマーカーであるウレアーゼ酵素活性を直接測定します。非侵襲的で結果が早いため、病院、診断ラボ、在宅環境で広く好まれています。

UBTはリアルタイムの感染状態を提供するため、治療モニタリングや除菌確認のためのゴールドスタンダードとして、医療専門家に支持されています。この検査は世界の保健機関からも支持されており、さらに普及が進んでいます。技術の進歩により、携帯可能で使いやすい呼気検査装置が開発され、アクセシビリティが向上しています。さらに、胃疾患の有病率の上昇と政府支援のスクリーニング・プログラムが市場の成長を支えています。効率的で患者に優しい診断への需要が高まる中、UBTは依然として非侵襲的ピロリ菌検査として最も広く使用されています。

市場は技術によって3つのカテゴリーに分類されます：分子診断法、免疫測定法、クロマトグラフィー技術です。分子診断法は、その高い感度、特異性、低菌量の検出能力により、非侵襲的ピロリ菌検査市場を独占しています。従来の方法とは異なり、分子診断、特にポリメラーゼ連鎖反応（PCR）ベースの検査は、ピロリ菌DNAを直接同定するため、無症状の患者でも正確な結果が得られます。そのため、臨床検査室や調査現場で好んで使用されています。

リアルタイムPCR（qPCR）と次世代シークエンシング（NGS）の採用が進み、診断精度がさらに向上しています。分子検査は迅速な結果を提供するため、繰り返し検査の必要性を減らし、タイムリーな治療決定を可能にします。さらに、これらの技術は抗生物質耐性の検出を可能にし、効果的な治療戦略を導くのに役立ちます。政府や医療機関は、胃疾患管理を改善するために高度な診断技術を推進しており、需要を牽引しています。診断の自動化とポイントオブケア分子検査の進歩が続く中、分子診断法は依然としてこの市場をリードする技術です。

非侵襲的ヘリコバクターピロリ検査市場：地域別分析

アジア太平洋地域の非侵襲的ピロリ菌検査市場は、ピロリ菌感染の高い有病率と胃腸疾患に対する意識の高まりにより拡大しています。中国、インド、日本などの国々では、ピロリ菌に関連する疾患の負担が大きく、早期かつ正確な診断に対する需要が高まっています。尿素呼気試験（UBT）や便中抗原試験（SAT）の採用は、その信頼性と非侵襲性により増加しています。胃がん検診プログラムを推進する政府のイニシアチブは、市場の成長をさらに後押ししています。医療インフラの拡大、可処分所得の増加、医療ツーリズムの増加により、この地域では高度な診断へのアクセシビリティが高まっています。さらに、eコマース・プラットフォームを通じて在宅検査キットが入手しやすくなっていることも、市場浸透を後押ししています。革新的な診断ソリューションに対する技術の進歩と規制状況の承認が、引き続き市場情勢を形成しています。

中国における非侵襲的ピロリ菌検査市場は、ピロリ菌感染の有病率が高く、人口の50％近くが感染していることから、力強い成長を遂げています。胃疾患、潰瘍、胃がんリスクに対する意識の高まりが、早期かつ非侵襲的な診断方法に対する需要を促進しています。中国政府は胃がん検診プログラムを推進しており、市場拡大をさらに加速させています。

尿素呼気試験（UBT）は、その高い精度と利便性により、中国で最も広く使用されている方法です。便中抗原検査（SAT）の採用も、特に病院や診断研究所で増加しています。一方、eコマース・プラットフォームや遠隔医療サービスの台頭により、在宅ピロリ菌検査キットの利用可能性が高まっています。消費者は、利便性、手頃な価格、通院回数の削減などの理由から、自宅での診断を好んでいます。

非侵襲的ヘリコバクターピロリ検査市場：競合情勢

非侵襲的ヘリコバクターピロリ検査市場は競争が激しく、各社は市場シェア拡大のために技術進歩、製品革新、戦略的提携に注力しています。Thermo Fisher Scientific社、Abbott社、DiaSorin社などの大手企業は、分子診断、免疫測定ベースのキット、尿素呼気試験で優位を占めています。研究開発投資の増加により検査精度が向上し、診断ラボの自動化により効率が向上しています。

在宅検査キットやデジタル医療ソリューションの台頭が競争をさらに激化させています。各社はまた、特に新興市場において世界な販売網を拡大しています。規制当局の承認と政府の支援によるスクリーニング・プログラムは、引き続き市場力学に影響を与えています。

目次

第1章 非侵襲的ヘリコバクターピロリ検査市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 非侵襲的ヘリコバクターピロリ検査の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 非侵襲的ヘリコバクターピロリ検査市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 非侵襲的ヘリコバクターピロリ検査市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 非侵襲的ヘリコバクターピロリ検査の市場情勢

  • 非侵襲的ヘリコバクターピロリ検査の市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 非侵襲的ヘリコバクターピロリ検査市場：検査の種類別

  • 概要
    • セグメント別シェア分析：検査の種類別
    • 尿素呼気試験（UBT）
    • 便抗原検査（SAT）
    • 血液抗体検査

第8章 非侵襲的ヘリコバクターピロリ検査市場：技術別

  • 概要
    • セグメント別シェア分析：技術別
    • 分子診断法
    • 免疫診断法
    • クロマトグラフィー技術

第9章 非侵襲的ヘリコバクターピロリ検査市場：流通チャネル別

  • 概要
    • セグメント別シェア分析：流通チャネル別
    • 機械翻訳の統合
    • 病院薬局
    • 小売薬局
    • オンライン薬局

第10章 非侵襲的ヘリコバクターピロリ検査市場：エンドユーザー別

  • 概要
    • セグメント別シェア分析：エンドユーザー別
    • エンドユーザー別セグメントシェア分析
    • 病院・診療所
    • 診断検査室
    • 在宅医療

第11章 非侵襲的ヘリコバクターピロリ検査市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ（LATAM）
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ（MEA）
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析：非侵襲的ヘリコバクターピロリ検査業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • Thermo Fisher Scientific Inc.
    • DiaSorin SpA
    • Abbott Laboratories
    • Bio-Rad Laboratories, Inc.
    • QuidelOrtho Corporation
    • Meridian Bioscience, Inc.
    • Coris BioConcept
    • Sekisui Diagnostics
    • Alfa Scientific Designs, Inc.
    • Halyard Health, Inc.
    • Kibion AB
    • Shenzhen Zhonghe Headway Bio-Sci &Tech Co., Ltd.
    • CerTest Biotec SL
    • BIOHIT HealthCare Ltd.
    • Medline Industries, LP
    • Cardinal Health, Inc.
    • Luminex Corporation

第13章 AnalystViewの全方位的分析

目次
Product Code: ANV4933

REPORT HIGHLIGHT

Non-invasive Helicobacter Pylori Testing Market size was valued at US$ 297.33 Million in 2024, expanding at a CAGR of 7.50% from 2025 to 2032.

The non-invasive Helicobacter pylori (H. pylori) testing market focuses on diagnostic methods that detect infections without requiring endoscopic procedures. These tests include urea breath tests (UBT), stool antigen tests (SAT), and blood antibody tests. UBT is highly accurate, detecting urease enzyme activity, while SAT identifies bacterial antigens in stool samples. Blood tests check for antibodies but are less reliable for active infections. The market is driven by the high prevalence of H. pylori, linked to ulcers and gastric cancer, and the increasing preference for non-invasive diagnostics. Growing awareness, improved healthcare access, and advancements in point-of-care testing further boost demand. North America, Europe, and Asia-Pacific lead the market due to well-established healthcare systems and rising gastrointestinal disease cases. Regulatory approvals and innovations in diagnostic technology continue to shape market expansion.

Non-invasive Helicobacter Pylori Testing Market- Market Dynamics

Rising demand for home-based H. pylori testing kits for convenience.

The growing demand for home-based H. pylori testing kits is a key driver in the non-invasive H. pylori testing market. Consumers prefer convenient, at-home diagnostic solutions that eliminate the need for clinical visits. These kits offer privacy, ease of use, and quick results, making them attractive for early detection. The rise of telemedicine and digital healthcare platforms further supports their adoption, allowing remote consultations based on test results. Additionally, increasing awareness about gastric diseases and preventive healthcare fuels market growth. Advancements in rapid antigen and breath test technologies enhance the accuracy and reliability of at-home testing. Regulatory approvals for self-testing solutions are expanding accessibility, especially in regions with limited healthcare infrastructure. Growing e-commerce penetration also boosts sales, making these kits widely available. As healthcare shifts toward personalized and preventive medicine, home-based H. pylori tests are expected to see strong demand.

Non-invasive Helicobacter Pylori Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.50% over the forecast period (2025-2032)

Based on Test Type segmentation, Urea Breath Test (UBT) was predicted to show maximum market share in the year 2024

Based on Technology segmentation, Molecular Diagnostics was the leading Technology in 2024

Based on distribution segmentation, Hospital-Based Pharmacies was the leading distribution in 2024

Based on End-user segmentation, Hospitals & Clinics was the leading End-user in 2024

On the basis of region, Asia-Pacific was the leading revenue generator in 2024

Non-invasive Helicobacter Pylori Testing Market- Segmentation Analysis:

The Global Non-invasive Helicobacter Pylori Testing Market is segmented on the basis of Test Type, Technology, Distribution, end-user, and Region.

The market is divided into three categories based on Test Type: Urea Breath Test (UBT), Stool Antigen Test (SAT), Blood Antibody Test. The Urea Breath Test (UBT) dominates the non-invasive H. pylori testing market due to its high accuracy, ease of use, and reliability in detecting active infections. Unlike blood antibody tests, which cannot distinguish between past and present infections, UBT directly measures urease enzyme activity, a key marker of H. pylori presence. It is widely preferred in hospitals, diagnostic labs, and home-based settings due to its non-invasive nature and quick results.

Healthcare professionals favor UBT because it provides real-time infection status, making it the gold standard for treatment monitoring and eradication confirmation. The test is also endorsed by global health organizations, further increasing adoption. Technological advancements have led to portable and easy-to-use breath test devices, enhancing accessibility. Additionally, the rising prevalence of gastric diseases and government-backed screening programs support market growth. With increasing demand for efficient and patient-friendly diagnostics, UBT remains the most widely used non-invasive H. pylori test.

The market is divided into three categories based on Technology: Molecular Diagnostics, Immunoassay-Based Testing, Chromatographic Techniques. Molecular Diagnostics dominates the non-invasive H. pylori testing market due to its high sensitivity, specificity, and ability to detect low bacterial loads. Unlike traditional methods, molecular diagnostics, particularly Polymerase Chain Reaction (PCR)-based tests, identify H. pylori DNA directly, ensuring accurate results even in asymptomatic patients. This makes it a preferred choice in clinical laboratories and research settings.

The increasing adoption of real-time PCR (qPCR) and next-generation sequencing (NGS) has further improved diagnostic precision. Molecular tests provide rapid results, reducing the need for repeated testing and enabling timely treatment decisions. Moreover, these technologies allow for antibiotic resistance detection, helping guide effective treatment strategies. Governments and healthcare organizations are promoting advanced diagnostic techniques to improve gastric disease management, driving demand. As automation in diagnostics and point-of-care molecular tests continue to advance, molecular diagnostics remains the leading technology in this market.

Non-invasive Helicobacter Pylori Testing Market- Geographical Insights

The Asia-Pacific non-invasive H. pylori testing market is expanding due to the high prevalence of H. pylori infections and increasing awareness of gastrointestinal diseases. Countries like China, India, and Japan have a significant burden of H. pylori-related conditions, driving the demand for early and accurate diagnostics. The adoption of urea breath tests (UBT) and stool antigen tests (SAT) is rising due to their reliability and non-invasive nature. Government initiatives promoting gastric cancer screening programs further support market growth. The expanding healthcare infrastructure, rising disposable income, and growing medical tourism in the region enhance accessibility to advanced diagnostics. Additionally, the increasing availability of home-based testing kits through e-commerce platforms is fueling market penetration. Technological advancements and regulatory approvals for innovative diagnostic solutions continue to shape the market landscape.

The non-invasive H. pylori testing market in China is witnessing strong growth due to the high prevalence of H. pylori infections, affecting nearly 50% of the population. The increasing awareness about gastric diseases, ulcers, and gastric cancer risks is driving the demand for early and non-invasive diagnostic methods. The Chinese government has been promoting gastric cancer screening programs, further accelerating market expansion.

Urea breath tests (UBT) are the most widely used method in China due to their high accuracy and convenience. The adoption of stool antigen tests (SAT) is also growing, particularly in hospitals and diagnostic laboratories. Meanwhile, the availability of home-based H. pylori testing kits is increasing, driven by the rise of e-commerce platforms and telemedicine services. Consumers prefer at-home diagnostics due to convenience, affordability, and reduced hospital visits.

Non-invasive Helicobacter Pylori Testing Market- Competitive Landscape:

The non-invasive H. pylori testing market is highly competitive, with companies focusing on technological advancements, product innovation, and strategic collaborations to expand their market share. Leading players such as Thermo Fisher Scientific, Abbott, and DiaSorin dominate with molecular diagnostics, immunoassay-based kits, and urea breath tests. Increasing R&D investments are enhancing test accuracy, while automation in diagnostic labs is improving efficiency.

The rise of home-based testing kits and digital healthcare solutions is further intensifying competition. Companies are also expanding their global distribution networks, especially in emerging markets. Regulatory approvals and government-backed screening programs continue to influence market dynamics.

Recent Developments:

In July 2023, Meridian Bioscience secured FDA clearance for its latest H. pylori diagnostic test, Premier HpSA Flex, marking a significant advancement in non-invasive testing. This development strengthened the company's position in the non-invasive H. pylori testing market and enhanced its diagnostic offerings.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NON-INVASIVE HELICOBACTER PYLORI TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Thermo Fisher Scientific Inc.
  • DiaSorin S.p.A.
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • QuidelOrtho Corporation
  • Meridian Bioscience, Inc.
  • Coris BioConcept
  • Sekisui Diagnostics
  • Alfa Scientific Designs, Inc.
  • Halyard Health, Inc.
  • Kibion AB
  • Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
  • CerTest Biotec S.L.
  • BIOHIT HealthCare Ltd.
  • Medline Industries, LP
  • Cardinal Health, Inc.
  • Luminex Corporation

GLOBAL NON-INVASIVE HELICOBACTER PYLORI TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Urea Breath Test (UBT)
  • Stool Antigen Test (SAT)
  • Blood Antibody Test

GLOBAL NON-INVASIVE HELICOBACTER PYLORI TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Molecular Diagnostics
  • Immunoassay-Based Testing
  • Chromatographic Techniques

GLOBAL NON-INVASIVE HELICOBACTER PYLORI TESTING MARKET, BY DISTRIBUTION- CHANNEL MARKET ANALYSIS, 2019 - 2032

  • Machine Translation Integration
  • Hospital-Based Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

GLOBAL NON-INVASIVE HELICOBACTER PYLORI TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Care Settings

GLOBAL NON-INVASIVE HELICOBACTER PYLORI TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Non-invasive Helicobacter Pylori Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Non-invasive Helicobacter Pylori Testing Market Snippet by Test Type
    • 2.1.2. Non-invasive Helicobacter Pylori Testing Market Snippet by Technology
    • 2.1.3. Non-invasive Helicobacter Pylori Testing Market Snippet by Distribution Channel
    • 2.1.4. Non-invasive Helicobacter Pylori Testing Market Snippet by End-user
    • 2.1.5. Non-invasive Helicobacter Pylori Testing Market Snippet by Country
    • 2.1.6. Non-invasive Helicobacter Pylori Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Non-invasive Helicobacter Pylori Testing Key Market Trends

  • 3.1. Non-invasive Helicobacter Pylori Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Non-invasive Helicobacter Pylori Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Non-invasive Helicobacter Pylori Testing Market Opportunities
  • 3.4. Non-invasive Helicobacter Pylori Testing Market Future Trends

4. Non-invasive Helicobacter Pylori Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Non-invasive Helicobacter Pylori Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Non-invasive Helicobacter Pylori Testing Market Landscape

  • 6.1. Non-invasive Helicobacter Pylori Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Non-invasive Helicobacter Pylori Testing Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 7.1.2. Urea Breath Test (UBT)
    • 7.1.3. Stool Antigen Test (SAT)
    • 7.1.4. Blood Antibody Test

8. Non-invasive Helicobacter Pylori Testing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. Molecular Diagnostics
    • 8.1.3. Immunoassay-Based Testing
    • 8.1.4. Chromatographic Techniques

9. Non-invasive Helicobacter Pylori Testing Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2024 & 2032 (%)
    • 9.1.2. Machine Translation Integration
    • 9.1.3. Hospital-Based Pharmacies
    • 9.1.4. Retail Pharmacies
    • 9.1.5. Online Pharmacies

10. Non-invasive Helicobacter Pylori Testing Market - By End-user

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
    • 10.1.2. Hospitals & Clinics
    • 10.1.3. Diagnostic Laboratories
    • 10.1.4. Home Care Settings

11. Non-invasive Helicobacter Pylori Testing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Non-invasive Helicobacter Pylori Testing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.2.8. The U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Non-invasive Helicobacter Pylori Testing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Non-invasive Helicobacter Pylori Testing Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Non-invasive Helicobacter Pylori Testing Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Non-invasive Helicobacter Pylori Testing Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Non-invasive Helicobacter Pylori Testing Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Thermo Fisher Scientific Inc.
    • 12.2.2. DiaSorin S.p.A.
    • 12.2.3. Abbott Laboratories
    • 12.2.4. Bio-Rad Laboratories, Inc.
    • 12.2.5. QuidelOrtho Corporation
    • 12.2.6. Meridian Bioscience, Inc.
    • 12.2.7. Coris BioConcept
    • 12.2.8. Sekisui Diagnostics
    • 12.2.9. Alfa Scientific Designs, Inc.
    • 12.2.10. Halyard Health, Inc.
    • 12.2.11. Kibion AB
    • 12.2.12. Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
    • 12.2.13. CerTest Biotec S.L.
    • 12.2.14. BIOHIT HealthCare Ltd.
    • 12.2.15. Medline Industries, LP
    • 12.2.16. Cardinal Health, Inc.
    • 12.2.17. Luminex Corporation

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us